BOT - Anything but charting, page-6929

from memory both rosacea / acne & anti microbial are using a synthetic cbd and a couple in combo with primatex (can't remember spelling).

thus you have data and learnings to leverage otherwise you will have to repeat some steps. from memory both had very similar methods of action that they used as evidence to support each other.

I think we will also find that derma is far cheaper than targeting 'superbugs'. so good to leverage the initial insights before taking on the more expensive trials of superbugs.

sure if we had a couple 100 millions we would but we don't so it's not an option so let's not bother wasting breath.

the key request from shareholders was to become revenue generating to support these much longer ambitions (decades) and management are directly focused on the goal. (they went and found another product to get us there quicker) we all know that bio is capital heavy with long lead times to revenue if you are lucky enough to ever get to approval